Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors Meeting Abstract
| Authors: | Messersmith, W.; Rasco, D.; De Bono, J.; Wang-Gillam, A.; Park, W.; Nickle, D.; Galkin, A.; Ferguson, B.; Carter, L.; Zhou, L.; Dupont, J.; Chaney, M.; Bendell, J.; Bruey, J. M. |
| Abstract Title: | Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors |
| Meeting Title: | 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 8 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Nov 9-14 |
| Meeting Location: | Virtual |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2020-11-01 |
| Start Page: | A236 |
| End Page: | A237 |
| Language: | English |
| ACCESSION: | WOS:000616665300378 |
| DOI: | 10.1136/jitc-2020-SITC2020.0389 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 389 -- Source: Wos |
